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Abstract: A diabetic foot ulcer is an open wound that can become sore and frequently occurs
in diabetic patients. Alginate has the ability to form a hydrophilic gel when in contact with a
wound surface in diabetic patients. Xanthones are the main compounds of mangosteen rind and
have antibacterial and anti-inflammatory properties. The purpose of this research was to evaluate
the wound healing and antioxidants assay with a combination of alginate from S. ilicifolium and
mangosteen rind combination extracts on a diabetic mice model. The characterization of alginate
was carried out by size exclusion chromatography with multiple angle laser light scattering (SEC-
MALLS) and thermogravimetric analysis (TGA). The M/G ratio of alginate was calculated by using
proton nuclear magnetic resonance (1H NMR). The antioxidant activity of mangosteen rind and
the combination extracts was determined using the DPPH method. The observed parameters were
wound width, number of neutrophils, macrophages, fibrocytes, fibroblasts, and collagen densities.
The 36 male mice were divided into 12 groups including non-diabetic control (NC), diabetes alginate
(DA), alginate–mangosteen (DAM), and diabetes control (DC) groups in three different groups by a
histopathology test on skin tissue. The treatment was carried out for 14 days and mice were evaluated
on Days 3, 7, and 14. The SEC-MALLS results showed that the molecular weight and dispersity index
(Ð) of alginate were 2.77 × 104 Dalton and 1.73, respectively. The M/G ratio of alginate was 0.77 and
described as single-stage decomposition based on TGA. Alginate, mangosteen rind extract, and their
combination were divided into weak, medium, and strong antioxidant, respectively. The treatment
of the DA and DAM groups showed a decrease in wound width and an increase in the number of
fibrocytes, fibroblasts, and macrophages. The number of neutrophils decreased while the percentage
of collagen densities increased for all the considered groups.
Keywords: alginate; Sargassum ilicifolium; mangosteen rind; wound healing; diabetic mice
1. Introduction
Diabetes mellitus (DM) is a metabolic disease caused by the disruption of the glucose
metabolism in the body [1]. DM can cause changes in skin homeostasis resulting in
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changes in metabolism and several complications, such as vasculopathy and neuropathy [2].
Diabetes is usually accompanied by the emergence of foot ulcer disease or gangrene,
palpable femoral and popliteal pulses, and the absence of foot pulses [3]. Foot ulcer disease
and gangrene are cases of disease that often occur in people with DM and usually begin
with the appearance of wounds. In general, there are many ways to treat open wounds in
diabetic patients: one of them being the use of ointments as topical medication. Agrawal
et al. (2014) reported that wounds can be healed using antibiotics, either used topically,
directly on the wound, or orally [4]. Diabetic wound healing can be disrupted if the patient
has poor blood sugar control and therapy, as well as the presence of bacteria on the wound
surface that causes infection [5]. In fact, the problems that occur during the wound-healing
process make the wound worsen, e.g., by increasing the reactive oxygen species (ROS) level
and oxidative stress. Both of these problems can disrupt the wound-healing process, so the
healing takes longer. In normal conditions, ROS such as hydrogen peroxide (H2O2) and
superoxide act as cellular messengers to stimulate wound healing [6]. Increasing the level
of ROS has a beneficial effect but, in some cases, can also cause tissue damage [7]. When
diabetic complications occur, the ROS level and oxidative stress start causing cell death
and tissue damage via several mechanisms [8]. Disproportion between antioxidants and
ROS disturbed by a depletion of antioxidants or an accumulation of ROS causes oxidative
stress [9]. This situation might be resolved through the application of antioxidants. Lobo
et al. (2010) reported that antioxidant molecules contribute an electron to make a free
radical become neutral, thus reducing its capacity for cellular damage through their free
radical scavenging property [10].
Alginate is a natural polymer that contains β-D-mannuronic acid (M) and α-L-
guluronic acid (G) blocks [11,12]. The main source of alginate is the various genera of
brown seaweed [12]. Alginate as a topical medicinal material has been chosen because it is
considered capable in maintaining the humidity around the wound, minimizing bacterial
infections, and easing the wound-healing process [13]. Alginate has been used in several
types of wounds, including pressure, diabetic, venous ulcers, and some open wounds due
to its ability as a good absorbent and gel-forming agent [14,15].
Mangosteen rind has been a traditional medicine to treat skin trauma and infections
for many decades [16]. Several studies have reported that xanthones (such as α-mangostin)
are the main compounds found in mangosteen rind. Xanthone has antibacterial, anti-
inflammatory, antioxidant, anticancer, and cardioprotective activities [17]. In the present
paper, the histopathology of wound healing on a diabetic mice model by using a composite
of alginate from S. duplicatum and okra combination extracts is described. Here, we
report the wound-healing and antioxidant evaluations of alginate from S. ilicifolium and
mangosteen rind combination extracts on a diabetic mice model.
2. Materials and Methods
2.1. Materials
S. ilicifolium samples were taken from Kei Island, Maluku, Indonesia in July 2018.
Identification was performed at the Oceanographic Research Center, LIPI, Jakarta, Indone-
sia (Approval Reference Number: 1/3/18-id/2018). Mangosteen (Garcinia mangostana)
was purchased from the Rungkut district (Surabaya, Indonesia). The species identification
was carried out at the Biosystem Laboratory of the Department of Biology of Airlangga
University.
2.2. Sodium Alginate Extraction
The S. ilicifolium was dried, cut into pieces, and grounded to powder. The dried S.
ilicifolium was added in a Becker in 0.1% KOH, soaked for an hour, and filtered. Then, 1%
HCl (1:30 w/v) was added to the sample and stirred for an hour, then it was filtered and
washed using water until a neutral pH was reached. The sample was then soaked with
2% Na2CO3 at ±70
◦C for two hours and filtered. The filtrate was added with 10% HCl
to pH 2.8–3.2 or until a gel was formed and 2% Na2CO3 until neutral pH was added to
Appl. Sci. 2021, 11, 4651 3 of 18
the gel. Then, 4% NaOCl (1:2 v/v) was added to the mixture. The alginate extract was
pipetted into 2-propanol solution in a 1:2 v/v ratio and slowly stirred until a sodium alginate
fiber was formed. The sodium alginate fiber was dried and grounded to form sodium
alginate powder.
2.3. Analysis of Sodium Alginate
2.3.1. Proton Nuclear Magnetic Resonance (1H NMR) Spectroscopy
1H NMR spectroscopy analyses were conducted on a JEOL JNM-ECS400A spectrom-
eter (JEOL, Peabody, MA, USA) at a frequency of 400 MHz. D2O was used as the NMR
solvent if not otherwise detailed. All samples were freeze dried before analysis.
2.3.2. Size Exclusion Chromatography with Multi-Angle Laser Light Scattering
(SEC-MALLS) Analysis
The molecular weight of alginate and its classification were analyzed using the gel
permeation chromatography technique by using a Shimadzu HPLC system (Shimadzu
UK Limited, Milton Keynes, UK) comprising a CBM-20A Controller, LC-20AD Pump with
degasser, SIL-20A Autosampler, and SPD-20A detector; HELEOS-II light-scattering and
Optilab rEx refractive index detectors were provided by Wyatt. A PL aquagel-OH mixed
column (7.5 × 300 mm, 8 µm particle size; Agilent Technologies, Santa Clara, CA, USA)
and a PL aquagel-OH mixed guard column (7.5 × 50 mm, 8 µm particle size; Agilent
Technologies, Santa Clara, CA, USA) were used as the stationary phase. The mobile
phase was a 50 mM sodium nitrate solution with a flow rate of 0.5 mL/min [11]. The
alginate solution (1.5 mg mL−1), dissolved in deionized water, was filtered through a nylon
membrane (Whatman, UK) before analysis. The value of 0.165 was used as the dn dc−1
grade [18].
2.3.3. Thermogravimetric Analysis (TGA)
TGA was carried out on a PL Thermal Sciences STA 625 thermal analyzer (PL Ther-
mal Science Limited, Surrey, UK). A total of 10 mg of accurately weighed sample in an
aluminum sample cup was placed into the furnace with a N2 flow of 100 mL min
−1 and
heated from room temperature to 625 ◦C at a heating rate of 10 ◦C min−1. From the TGA
profiles, the temperatures at 10% and 50% mass loss (TD10 and TD50, respectively) were
analyzed afterwards.
2.4. Extraction of Mangosteen Rind
The dry mangosteen rinds were mashed into small fragments. The fragments were
then macerated using 96% ethanol for three days. Samples were filtered and concentrated
under vacuum. The extract was freeze dried and kept in 4 ◦C for the next step.
2.5. Antioxidant Assay and Analysis of Total Phenolic Content
Antioxidant assays were performed on alginate from S. ilicifolium, mangosteen rind
extract, and a combination of alginate–mangosteen rind extracts by the 2,2-diphenyl-1-
picryl-hydrazyl-hydrate (DPPH) free radical method. The concentration of DPPH and
stock solutions were 50.0 and 1000.0 µg/mL, respectively. The extracts were diluted in
concentration variations of 200.0, 150.0, 125.0, 100.0, 75.0, 50.0, 35.0, 25.0, 15.0, 10.0, and
6.0 µg/mL of sample solution in methanol (200 µL) and 50 µL of DPPH was added into
96-well plates. Subsequently, the mixtures were incubated for 30 min in a dark chamber
and the absorbance was measured at 517 nm on an ELISA plate reader.
The total phenolic content of alginate and mangosteen rind extract was determined by
the colorimetric method, referring to the procedure of Malik et al. (2015) with some modi-
fications and with gallic acid as standard [19]. The standard solutions and samples with
concentrations of 10, 20, 30, 40, and 50 ppm were added with 0.4 mL of Folin–Ciocalteau
reagent. After 4–8 min, 4.0 mL of 7% Na2CO3 solution was added and aquabidestilata
was added to 10 mL, and then it was allowed to stand for 2 h at room temperature. The
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absorbance of solution was analyzed at a maximum wavelength of 744.8 nm; a calibration
curve was made for the relationship between the concentration of gallic acid (µg/mL) and
the absorbance.
2.6. Induction of Diabetic Mice
The BALB/c strains of adult male mice (Mus musculus) were obtained from the Faculty
of Pharmacy, Airlangga University, Surabaya. The mice were 3–4 months old with a weight
range of 20–35 g. Ethical clearance for treating animals was obtained from the Faculty of
Veterinary Medicine, Airlangga University, Surabaya, Indonesia with License Reference
Number: 2. KE. 049.04.2019.
The mice were treated in a 12 h light and 12 h dark lighting system for a couple
of weeks. During acclimatization for the experiment, the mice were fed (oral dose of
0.3 mL) with lard three times per week during 3 weeks in order to achieve a high fat diet.
Streptozotocin (STZ) was injected for 8 days by using the 30 mg/kg body weight using
multiple low dose method of 0.15 mL intraperitoneally (i.p) to induce type II diabetes
mellitus [20]. The mice were weighed before and after treatment. The level of blood glucose
was measured after STZ induction at 3, 7, and 14 days of treatment.
2.7. Animal Grouping and Treatment
The group of mice (12 groups) were separated: (a) three groups for no treatment as
normal (N) and (b) nine diabetic groups for treatment (D), consisting of three mice in each
group for 3, 7, and 14 days of treatment [20]. The nine treatment groups were classified
into three categories: (1) three groups for diabetic control (DC3, DC7, and DC14); (2) three
groups for alginate treatment (DA3, DA7, and DA14); and (3) three groups for alginate–
mangosteen rind extract treatment (DAM3, DAM7, and DAM14). A centimeter wound
on the mice’s glutea (buttocks) was generated. Each group was smeared with Vaseline
(untreated and DC), vaseline–alginate (DA), and vaseline–alginate–mangosteen rind extract
ointments (DAM). A single dose of 50 mg/kg body weight ointment was generated for
treatment. The animal number replication was referred to the Federer formula (1967) [21].
2.8. Histopathology Analysis of Wound Healing
The histopathology experiments of wound healing were conducted at the Pathol-
ogy Laboratory of the Faculty of Veterinary Medicine, Airlangga University. A micro-
scope at 400 times magnification was used for the observation of fibroblasts, fibrocytes,
macrophages, neutrophils, and collagen density. The width of the wound was analyzed
using 40 times magnification under an optical microscope.
2.9. Statistical Analysis
The wound-healing measurements are illustrated as a mean ± standard error mean
(SEM). The wound-healing data analysis was conducted by a normality and homogeneity
test, one-way ANOVA, and Duncan test. If the results of normality and homogeneity
were not qualified (α = 0.05), non-parametric tests such as the Kruskal–Wallis and Mann–
Whitney tests were applied. All the statistical analyses were calculated using an IBM with
SPSS 20.0 software.
3. Results
3.1. Analysis of Sodium Alginate
3.1.1. Proton Nuclear Magnetic Resonance (1H NMR) Analysis
The mannuronate-to-guluronate (M/G) ratio of alginate was determined by 1H NMR.
The spectrum of alginate is shown in Figure 1. The proton signals of alginate at a chemical
shift in the 4.8–4.0 ppm range correspond to the G2/M2, while the signals at 5.8–5.0 ppm
correspond to the G1/M1, respectively. The G1 and M1 are the most de-shielded protons
(δ 5.8–5.1 and 5.5–5.1, respectively). M1 is more shielded than G1, because G1 is located at
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an equatorial position in comparison to an axial one in M1. The M/G ratio of alginate was
0.77 and was determined by the integration as previously reported [22].
δ
Figure 1. (A) Spectra of 1H NMR spectra of alginate from S. Ilicifolium (90 ◦C 128 scans); (B) detail of 1H NMR spectra
(90 ◦C 128 sc).
3.1.2. Size Exclusion Chromatography with Multi-Angle Laser Light Scattering
(SEC-MALLS) Analysis
The polydispersity index (Ð) and the molecular weight of alginate from S. ilicifolium
were analyzed by SEC-MALLS (Figure 2A). The number average molecular weight (MN)
and weight average molecular weight (MW) of alginate from S. ilicifolium were 1.49 × 10
4
and 2.77 × 104 Dalton, respectively. The Ð was found to be 1.73, which indicated that
alginate from S. ilicifolium has a good homogeneity and is classified as chain-growth
polymerization.
μ
Figure 2. (A) RI signal of size exclusion chromatography with multiple angle laser light scattering (SEC-MALLS) analysis
and (B) thermogravimetric analysis (TGA) of sodium alginate.
3.1.3. Thermogravimetric Analysis
Thermal stability and polymer matrix strength were analyzed using TGA by observing
the weight difference as the sample was heated at a constant rate. Figure 2B shows the
thermal stability and strength of the S. ilicifolium alginate polymer matrix. It was found that
5% of the mass was obscured (TD5) at 82
◦C and most probably indicated the water loss
(moisture). The 10% (TD10) and 20% mass loss occurred at 125
◦C and 235 ◦C, respectively,
indicating glycosidic bond destruction. The 50% (TD50) mass loss at 466
◦C indicated the
carbon turns into charcoal.
3.2. Antioxidant Assay and Analysis of Total Phenolic Content
An antioxidant assay was utilized to measure the inhibitory concentration (IC50) of
each compound. The antioxidant activity of alginate, mangosteen rind, and the combination
of alginate–mangosteen rind extracts was found using the DPPH method. The IC50 of
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alginate, mangosteen rind, and the combination of alginate–mangosteen rind extract was
297.60, 29.60, and 52.72 µg/mL, respectively (Table 1). The results showed that alginate
was a moderate antioxidant, mangosteen rind was strong antioxidant, and the combination
of alginate–mangosteen rind extracts was acting as a very powerful antioxidant. The total
phenolic content in the mangosteen rind extract was 32.94 mg GAE/g extract or 3.29%
(y = 0.0193x + 0.031; R2 = 0.9976).
Table 1. Antioxidant activity of alginate, mangosteen rind, and alginate–mangosteen rind combination.
Sample IC50 (µg/mL) Classification
S. ilicifolium alginate 120.88 Moderate antioxidant
Mangosteen rind extract 29.06 Powerful antioxidant
Alginate–mangosteen rind extract 52.72 Strong antioxidant
3.3. Measurement of Body Weight in Mice
The administration of lard for three weeks in a single oral dose (0.3 mL) can signifi-
cantly increase the body weight of mice (p < 0.05). The increase in the body weight of mice
ranged from 29 ± 3.42 g to 34 ± 2.83 g. Husen et al. (2019) reported that obesity caused by
excessive fat accumulation can induce various chronic diseases and complications such as
diabetes mellitus [23].
3.4. Measurement of Blood Glucose Level in Mice
STZ can increase blood sugar levels of up to more than 250 mg/dL in mice, as
presented in Table 2. Based on experiments, the blood sugar levels of the normal group
decreased significantly on Days 1 to 14 (p < 0.05). The blood glucose level in the DC
group decreased from Days 1 to 7 but increased on Day 14 (250.0 ± 10.6 mg/dL). The DA
group showed a decrease from Days 1 to 14 (250.0 ± 8.5 mg/dL to 209.0 ± 11.3 mg/dL).
Fluctuating changes in body weight were observed in the DAM mice group, but on Day 14
the blood sugar level decreased to 135.0 ± 7.1 mg/dL. On Day 14, the DAM mice showed
a normal blood sugar level (non-diabetic).
Table 2. Mean and standard deviation of blood glucose.
Group Treatment
Blood Glucose Level (mg/dL)
Day 1 Day 3 Day 7 Day 14
Normal (NC) 118.0 ± 4.2 117.0 ± 2.3 114.0 ± 2.8 110.0 ± 1.4
Diabetic (DC) 256.0 ± 4.9 250.0 ± 11.3 242.0 ± 2.1 250.0 ± 10.6
Alginate ointment (DA) 250.0 ± 8.5 230.0 ± 12.0 225.0 ± 2.8 209.0 ± 11.3
Alginate–mangosteen rind extract ointment (DAM) 251.0 ± 5.7 176.0 ± 5.7 182.0 ± 7.8 135.0 ± 7.1 **
Asterisk notation in the table shows the result of the statistical test (α < 0.05). ** notation shows insignificant differences with NC but
significant differences with DC. ** = 0.01 ≤ α < 0.05. n = 3 animals per time point.
3.5. Microscopic Evaluation of Wound Tissue
The microscopic evaluation of wound tissue included an evaluation of wound width,
the number of neutrophil cells, macrophages, fibrocytes, and fibroblasts, and the collagen
density in each group. The results of the histopathological microscopic observations in all
study groups are described in Figures 3 and 4.




Figure 3. Histopathology analysis of wound width was measured on the three variation times. A
circle in the picture indicates the wound width in the specimen. NC: normal group; DA: alginate
treatment group; DAM: alginate–mangosteen rind extract treatment group; and DC: diabetic group.
Based on microscopic observations, it can be seen that the DAM group revealed the
best wound-healing process for diabetic mice compared to other diabetic treatment groups.
The re-epithelization of DA and DAM occurred on Day 7 and wound closing occurred on
Day 14 for all groups. Figure 4 shows that the DAM group had the best re-epithelization
process among the groups.
Figure 4 shows the wound parameters in microscopic observation, where neutrophils
(green), macrophages (blue), fibrocytes (yellow), and fibroblasts (red) are shown by an
arrow in a different color. The number of neutrophils increased at Day 3 and decreased at
Day 7 and Day 14 for all groups. The number of macrophages increased at Day 3 to Day
7, and then declined at Day 14 for all groups. NC, DA, and DAM showed a significant
rise in the number of fibrocytes and fibroblasts at Day 7 to indicate re-epithelization and a
reduction at Day 14.
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Figure 4. Analysis of wound width on the three variation times. Green arrows: neutrophils; blue
arrows: macrophages; yellow arrows: fibrocytes; and red arrows: fibroblasts. NC: normal group;
DA: alginate treatment group; DAM: alginate–mangosteen rind extract treatment group; and DC:
diabetic group.
3.6. Parameter Analysis
3.6.1. Wound Width Determination
The width of the wound is defined as the distance between the epithelium (right–left)
that underwent a complete re-epithelialization quantifiable in microns. The width of the
wound for each group per day showed a significant difference (Figure 3). All groups
showed good results on Day 14 as the wound had closed in all groups. DAM showed
the best wound repair response in comparison with the NC group (2502.0 ± 10.4 µm and
726.0 ± 29.7 µm on Days 3 and 7, respectively) (Figure 5).
3.6.2. Neutrophil Measurement
Neutrophils are the onset of an inflammatory response in the recovery process of open
wounds and aim to clean microorganisms that enter the wound [24–26]. The number of
neutrophils showed significant differences both in the DA and DAM groups toward DC. A
decrease in the neutrophil count was observed in DAM from Days 3 to 14, similar to what
was observed for the NC group (Figure 6).
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Figure 5. Wound width at the three variation times. Notation on the graph shows the result of the
statistical test ( < 0.05). * and ** notation shows insignificant differences with NC but significant
differences with DC. * = 0.01 α < 0.05; ** = α ≤ 0.01. NC: normal group; DA: alginate treatment
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Figure 6. Number of neutrophils at the three variation times. Notation on the graph shows the
result of the statistical test (α < 0.05). * and ** notation shows insignificant differences with NC but
significant differences with DC. * = 0.01 ≤ < 0.05; ** = α ≤ 0.01. NC: normal group; DA: alginate
treatment group; DAM: alginate–mangosteen rind extract treatment group; and DC: diabetic group.
3.6.3. Macrophage Measurement
Macrophage secretion will increase massively as neutrophils decrease [26]. Figure 7
shows that the number of macrophages in the DC group showed a high increase due
to hyperglycemia and ROS, while the other groups experienced a decrease because they
did not experience these conditions. The DAM group gave a similar observation as the
NC group, wherein the graph of macrophages in this group was the same as the control
normal/non-diabetic group (Figure 7).
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Figure 7. Number of macrophages at the three variation times. Notation on the graph shows the
result of the statistical test (α < 0.05). * and ** notation shows insignificant differences with NC but
significant differences with DC. * = 0.01 ≤ α < 0.05; ** = α ≤ 0.01. NC: normal group; DA: alginate
treatment group; DAM: alginate–mangosteen rind extract treatment group; and DC: diabetic group.
3.6.4. Fibrocyte Measurement
Fibrocytes play a role in the process of differentiation of myofibroblasts in fibrosis and
wound healing [27]. In this study, the number of fibrocytes in the DAM groups on Days 3,
7, and 14 were close to the NC group, whereas the DC group showed the lowest number
of fibrocytes, i.e., almost one-third of the numbers recorded for the NC and DAM groups
(Figure 8).
α
≤ α α ≤
α
Figure 8. Number of fibrocytes at the three variation times. Notation on the graph shows the result
of the statistical test (α < 0.05).** notation shows insignificant differences with NC but significant
differences with DC. ** = α ≤ 0.01. NC: normal group; DA: alginate treatment group; DAM: alginate–
mangosteen rind extract treatment group; and DC: diabetic group.
3.6.5. Fibroblast Measurement
The histopathological observations are displayed in Figure 4. DAM showed the
highest number of fibroblasts, while DC showed the lowest number of fibroblasts (Figure 9).
The number of fibroblasts on Days 3 and 7 showed an increase but decreased on Day 14 in
all groups (Figure 9).
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Figure 9. Number of fibroblasts at the three variation times. Notation on the graph shows the result
of the statistical test (α < 0.05). * notation shows insignificant differences with NC but significant
differences with DC. * = 0.01 ≤ α < 0.05. NC: normal group; DA: alginate treatment group; DAM:
alginate–mangosteen rind extract treatment group; and DC: diabetic group.
3.6.6. Collagen Density Measurement
Observation of collagen density was conducted to determine the process of the for-
mation of new collagen in open wounds. Figure 10 shows that DAM presents the highest
collagen density compared to the other groups, while DC shows the lowest percentage of
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Figure 10. Collagen density was evaluated at the three variation times. Notation on the graph shows
the result of the statistical test (α < 0.05). * and ** notation shows insignificant differences with NC
but significant differences with DC. * = 0.01 ≤ α < 0.05; ** = α ≤ 0.01. NC: normal group; DA: alginate
treatment group; DAM: alginate–mangosteen rind extract treatment group; and DC: diabetic group.
4. Discussion
Sodium alginate was extracted from S. ilicifolium to give a pale-yellow solid with a
14.36% yield. The obtained yield is very similar to the one reported by Latifi et al. (2015),
who reported yields ranging from 12% to 16.5% [28]. Davis et al. (2004) extracted S. fluitans
and S. oligocystum using high temperature and base conditions to obtain 21.1–22.8% and
18.9–20.5% yields, respectively [29]. Mushollaeni (2011) reported that alginate from several
species of Sargassum sp. had 16.93 to 30.50% yields [30]. Based on this study, the yield of the
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extracted alginate not only depends on the extraction method and the Sargassum species
used but also on the seasonal variation. It is in fact well known that there are marked
seasonal variations of polysaccharide contents in seaweeds, as polysaccharides are stored
in winter as a food source and therefore a harvest at the end of summer will give higher
polysaccharide levels than in the spring.
The 1H NMR analysis of S. ilicifolium alginate showed that the signals in the range
4–4.8 ppm belong to protons from the β-glycosidic bond, whereas the signals between
5.1 and 5.8 ppm are resonances of protons from the α-glycosidic bond. The identification
was performed by comparison with the 1H NMR spectrum of alginate from Llanes et al.
(1997) [31]. The structure of alginate from S. ilicifolium consists of β-D-mannuronic acid
(4.3–4.8 ppm) and α-L-guluronic acid (5.1–5.8 ppm). The M/G ratio of alginate was deter-
mined by the integration of each proton with their monomers. The M/G ratio of alginate
was 0.77, indicating that S. ilicifolium alginate has a higher guluronic acid monomer than
mannuronic acid. The protons G1 and M1 are the most de-shielded protons (δ 5.1–5.8 and
5.1–5.5, respectively). M1 is more shielded than G1, because G1 is located at an equatorial
position in comparison to an axial one in M1. In fact, Llanes et al. performed a pretreatment
to partly hydrolyze the alginate before 1H NMR analysis, while in our case we decided to
work with non-hydrolyzed alginate as it was fully soluble in the NMR solvent. This can be
an explanation for the slightly more structured peaks and possibly also for the small shifts
downfield we observed.
The number of Mn and Mw of alginate were 1.49 × 10
4 and 2.77 × 104 Dalton, respec-
tively. Furthermore, the Mn and Mw obtained were used in the calculation of the dispersity
index (Ð) using the following equation:
Ð = Mw/Mn (1)
The dispersity index (Ð) was 1.73. The Ð value of alginate from S. ilicifolium was below
2, indicating that the extracted alginate showed good homogeneity and was classified as
chain-growth polymerization. Chain-growth polymerization is a process in which the high
molecular weight polymer is generated at the beginning of the polymerization process and
the polymer yield (the percentage conversion of the monomer into the polymer) gradually
increases with time [32]. Based on TGA, alginate from S. ilicifolium had a single-stage
decomposition curve (Figure 2B).
The antioxidant assay showed that the IC50 of alginate, mangosteen rind, and alginate–
mangosteen rind extract combination was 297.60, 29.60, and 52.0 µg/mL, respectively.
The results indicated that alginate was a weak antioxidant and mangosteen rind was a
powerful antioxidant, and when combined they produced a material with excellent an-
tioxidant properties. These observations could be linked to the fact that mangosteen rind
contains xanthones, such as α-mangostin and γ-mangostin, which have been reported to
exhibit anti-inflammatory, antioxidant, and radical scavenging activity [33–35]. According
to Thong et al. (2015), xanthones can capture free radicals in two ways: through hydrogen
atom transfer (HAT) to explain the antioxidant activity in the gas phase and the single
electron transfer–proton transfer (SETPT) mechanism that is thermodynamically favored
in water [36]. Strong antioxidant activity observed in the combination of alginate and man-
gosteen rind extract could possibly overcome ROS that occur in hyperglycemic conditions,
thus enhancing wound repair in diabetic mice.
The total phenolic content in mangosteen rind extract tends to be low due to several
factors, such as the type of mangosteen fruit, storage time, and the hardness of the rind.
According to Dangcham et al. (2008), the total phenolic content of mangosteen fruit will
decrease throughout the storage time [37]. Another study reported that the lignin content
and density of the damaged pericarp tissue would increase as a result of the hardening
of the fruit skin, while the total phenolic content decreased [38]. Mangosteen rind is
an essential, natural phenolic antioxidant source; at least ten phenolic acids have been
characterized in mangosteen rind [39,40]. Mangosteen rind contains bioactive substances,
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such as phenolic acids, flavonoids, anthocyanins, proanthocyanidins, (-)-epicatechin, and
xanthones, which have biological, medical, and antioxidant properties.
The administration of lard can significantly increase the body weight of mice. This
condition indicated increasing hyperglycemia and insulin resistance, and it will cause type
II DM [20]. Husen et al. (2019) reported that obesity caused by excessive fat accumulation
can induce various chronic diseases and complications such as diabetes mellitus [23]. The
administration of STZ was performed to increase the condition of hyperglycemia (increased
blood sugar level) [20]. The increase of blood sugar levels in three diabetic groups, namely
diabetic non-treated (DC), diabetic treated with alginate ointment (DA), and diabetic treated
in alginate–mangosteen rind extract ointment (DAM), of up to 250 mg/dL indicated that
the mice were in a diabetic condition. Based on experiments, the combination of alginate
and mangosteen rind extract proved able to reduce blood sugar levels (Table 2). Lee et al.
(2018) reported that mangosteen was able to increase insulin secretion in pancreatic B-cells
and protected cells from apoptosis, due to the presence of α-mangostin in mangosteen
fruit [41]. Jariyapongskul et al. (2015) reported that daily α-mangostin supplementation
in diabetic rats shows remarkable hypoglycemic and insulinotropic effects, a reduction in
plasma glycated hemoglobin, and a decrease in serum triglycerides and cholesterol [42].
It was expected that the administration of a topical combination of alginate and
mangosteen rind extract in diabetic wounds could reduce blood sugar levels by entering
the systemic circulation through the bloodstream. The entry of compounds found in topical
drugs through the bloodstream can enhance the host insulin level and the sensitivity of
somatic cells [43]. Therefore, the topical combination of alginate and mangosteen rind
extract can be classified as diadermic ointment. A diadermic ointment is a drug that is able
to enter the deepest skin tissue and enter the systemic circulation [44]. However, further
investigation is required to confirm whether the compounds responsible for reducing
the blood sugar levels are a combination of alginate and mangosteen rind extract or the
presence of other active compounds that have not been separated from the alginate during
extraction given the number of weak proton signals observed in the 1HNMR. In addition,
it is necessary to confirm the exact mechanism concerning how blood glucose levels can be
decreased by administering a topical combination of alginate and mangosteen rind extract.
The DAM group, which was treated by alginate–mangosteen rind extract combination,
showed a very significant decrease on Days 3 and 7, 2502.0 ± 10.4 and 726.0 ± 29.7,
respectively, compared to other groups (Table 3). On Day 14, all groups showed that the
wound had closed. The wound width of diabetic mice in the DAM group showed the
best activity when compared to the other tested conditions. This happened due to the
combination of alginate and mangosteen rind extract providing strong antioxidant activity
and thus decreasing ROS and increasing wound contraction and wound healing.
The diabetic group (DC) showed the greatest increase in the number of neutrophils in
comparison to other groups. Administration of the combined alginate and mangosteen
rind extracts (DAM) demonstrated that the neutrophil count in open wounds on diabetic
mice increased in the first 24–48 h and then decreased until Day 14 (55.0 ± 0.9 on Day
3 to 14.0 ± 0.2 cells/mm2 on Day 14), thus indicating that DAM could ease the process
of wound healing (Table 4). The decrease in the neutrophil count in the DAM group
occurred due to the presence of phenolic compounds from the mangosteen rind extract
that acted as antioxidants. Phenolic compounds are able to reduce the secretion of human
neutrophil elastase (HNE), which is an enzyme that can break down the components of the
extracellular matrix by reducing the number of neutrophils [45].
The macrophage count in the DC group showed a slight decrease on Day 14 compared
to the other groups, thus implying that the inflammation phase in the open wounds of
diabetic mice occurred for a longer duration than the normal group. Persistent inflamma-
tory conditions inhibit wound healing [46]. The presence of hyperglycemia and oxidative
stress (increased blood sugar levels and ROS) can affect the modulation and polarization of
macrophages, which could inhibit the healing process [27,47]. Therefore, the administration
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of alginate and mangosteen rind extracts to diabetic wounds could reduce the number of
macrophages in the wound almost as well as non-diabetic wounds (Table 5).
Table 3. Counts considering the mean and standard deviation of wound width.
Group Treatment
Wound Width (µm)
Day 3 Day 7 Day 14
Normal (NC) 2673.0 ± 22.9 882.0 ± 44.1 0.0 ± 0.0
Diabetic (DC) 4786.0 ± 63.9 3636 ± 37.0 0.0 ± 0.0
Alginate ointment (DA) 3030.0 ± 126.6 1002.0 ± 11.5 * 0.0 ± 0.0
Alginate–mangosteen rind ointment (DAM) 2502.0 ± 10.4 ** 726.0 ± 29.7 ** 0.0 ± 0.0
Asterisk notation in the table shows the result of the statistical test (α < 0.05). * and ** notation shows insignificant
differences with NC but significant differences with DC. * = 0.01 ≤ α < 0.05; ** = α ≤ 0.01.
Table 4. Cell counts considering the mean and standard deviation of neutrophils.
Group Treatment
Neutrophil (cells/mm2)
Day 3 Day 7 Day 14
Normal (NC) 57.0 ± 1.4 28.0 ± 4.9 11.0 ± 1.4
Diabetic (DC) 118.0 ± 1.2 55.0 ± 1.9 38.0 ± 1.4
Alginate ointment (DA) 77.0 ± 1.2 43.0 ± 6.4 28.0 ± 0.4
Alginate–mangosteen rind ointment (DAM) 55.0 ± 0.9 ** 35.0 ± 2.1 * 14.0 ± 0.2 **
Asterisk notation in the table shows the result of the statistical test (α < 0.05). * and ** notation shows insignificant
differences with NC but significant differences with DC. * = 0.01 ≤ α < 0.05; ** = α ≤ 0.01.
Table 5. Cell counts considering the mean and standard deviation of macrophages.
Group Treatment
Macrophage (cells/mm2)
Day 3 Day 7 Day 14
Normal (NC) 15.0 ± 0.5 21.0 ± 0.7 5.0 ± 0.2
Diabetic (DC) 37.0 ± 0.7 40.0 ± 3.1 17.0 ± 0.7
Alginate ointment (DA) 21.0 ± 2.1 26.0 ± 0.5 * 9.0 ± 0.2
Alginate–mangosteen rind ointment (DAM) 15.0 ± 0.5 ** 20.0 ± 0.5 ** 5.0 ± 0.2 **
Asterisk notation in the table shows the result of the statistical test (α < 0.05). * and ** notation shows insignificant
differences with NC but significant differences with DC. * = 0.01 ≤ α < 0.05; ** = α ≤ 0.01.
An increase in the fibrocyte count leads to an increase in collagen V production,
while lowering collagen I, III, and IV levels [48]. Fibrocyte differentiation can reduce
inflammatory conditions and tissue damage as well as improve the wound-healing and
tissue-remodeling process. The number of fibrocytes will increase with the increasing age
of the wound, and more than 15 fibrocytes indicated the age of the wound was between 9
and 14 days [27]. The administration of a topical combination of alginate and mangosteen
rind extract in the DAM group can increase the number of fibrocyte cells in diabetic open
wounds between Day 3 and Day 7, thus accelerating the process of angiogenesis. On the
other hand, the fibrocyte count decreased by Day 14, as shown in Table 6; this condition
indicated the wound had healed.
Table 6. Cell counts considering the mean and standard deviation of fibrocytes.
Group Treatment
Fibrocyte (cells/mm2)
Day 3 Day 7 Day 14
Normal (NC) 22.0 ± 0.5 26.0 ± 0.4 21.0 ± 0.5
Diabetic (DC) 10.0 ± 0.7 10.0 ± 0.9 9.0 ± 0.5
Alginate ointment (DA) 15.0 ± 0.5 19 ± 0.7 14.0 ± 1.9
Alginate–mangosteen rind ointment (DAM) 22.0 ± 0.2 ** 28 ± 0.5 ** 20.0 ± 0.7 **
Asterisk notation in the table shows the result of the statistical test (α < 0.05). ** notation shows insignificant
differences with NC, but significant differences with DC. ** = α ≤ 0.01.
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Fibroblasts are cells that have a role in the proliferation phase. These cells have the
function to regulate collagen, glycosaminoglycan, proteoglycan, fibronectin, and elastin
as the extracellular matrix components [49,50]. In addition, fibroblasts also play a role in
collagen. The presence of an increase and decrease in the number of fibroblasts is the same
as observed in the measurement of the number of fibrocytes in the wound. All groups
showed an increase in the number of fibroblasts on Day 7 and a decline on Day 14. A
decrease in the number of fibroblasts on Day 14 in all groups indicates that the healing
phase is at the remodeling stage (Table 7). The remodeling phase can be identified by
decreasing proliferation and inflammation, reorganization of the extracellular matrix, and
regression of newly formed capillary vessels [51]. The fibroblast count in the DAM group
was almost the same as the fibroblast count of the NC or normal group. This result indicated
that the administration of alginate–mangosteen rind extract combination was effective to
heal the open wound.
Table 7. Cell counts considering the mean and standard deviation of fibroblasts.
Group Treatment
Fibroblast (cells/mm2)
Day 3 Day 7 Day 14
Normal (NC) 22.0 ± 1.9 44.0 ± 2.6 27.0 ± 6.8
Diabetic (DC) 10.0 ± 0.2 24.0 ± 0.7 15.0 ± 0.5
Alginate ointment (DA) 16.0 ± 0.2 * 27.0 ± 0.7 20.0 ± 0.5 *
Alginate–mangosteen rind ointment (DAM) 28.0 ± 0.2 * 56.0 ± 0.5 31.0 ± 0.7 *
Asterik notation in the table shows the result of the statistical test (α < 0.05). * notation shows insignificant
differences with NC but significant differences with DC. * = 0.01 ≤ α < 0.05.
The treatment group of alginate and mangosteen rind extract of DAM showed sig-
nificant results at each observation on Days 3, 7, and 14 with 65.0 ± 1.4%, 85.0 ± 0.7%,
and 91.0 ± 0.7%, respectively (Table 8). The DAM group showed the highest percentage of
collagen density compared to other groups. The diabetic conditions increase the production
of ROS/RNS, which decreases the collagen synthesis [52]. An increase in the percentage of
collagen density in the DAM indicated an increase in collagen synthesis.
Table 8. Cell counts considering the mean and standard deviation of collagen density.
Group Treatment
Collagen Density (%)
Day 3 Day 7 Day 14
Normal (NC) 53.0 ± 1.4 76.0 ± 0.5 88.0 ± 0.9
Diabetic (DC) 32.0 ± 1.4 44.0 ± 0.2 65.0 ± 2.1
Alginate ointment (DA) 43.0 ± 2.8 * 65.0 ± 3.5 79.0 ± 0.7
Alginate–mangosteen rind ointment (DAM) 65.0 ± 1.4 * 85.0 ± 0.7 91.0 ± 0.7 **
Asterisk notation in the table shows the result of the statistical test (α < 0.05). * and ** notation shows insignificant
differences with NC but significant differences with DC. * = 0.01 ≤ α < 0.05; ** = α ≤ 0.01.
Achievement of the wound-healing process that occurred in DAM could be due to
compounds possessing antioxidant activity from the combined mangosteen peel. Moreover,
Kataria et al. (2014) reported that alginate is a good absorbent and gel formation agent
that has homeostatic properties [15]. Alginate has been used in several types of wounds,
including pressure wounds, diabetic wounds, and venous ulcers such as cavities and
multiple bleeding sores [14]. In addition, alginate acts as an antioxidant that can capture
free radicals and absorbs wound exudate.
5. Conclusions
The administration of a topical combination of alginate extracted from S. ilicifolium
and mangosteen rind extract (Garcinia mangostana) in diabetic open wounds is able to
accelerate the process of wound closure. This is evidenced with an increase in neutrophils,
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macrophages, fibrocytes, fibroblasts, and collagen density, which enhance the process of
re-epithelialization and the synthesis of collagen in the wound area. Alginate absorbs
wound exudate, and xanthones are known to have antioxidant and anti-inflammatory
activities. Xanthone is capable of capturing free radicals (ROS/RNS), which usually tend
to increase in diabetics. Therefore, it can be concluded that the combination of alginate and
mangosteen rind extract can improve the wound-healing process in diabetic mice.
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